|
LOC220729 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.919280E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.316820E-03 |
| Normal-vs-Stage2 |
3.575700E-02 |
| Normal-vs-Stage3 |
2.294400E-01 |
| Normal-vs-Stage4 |
1.498170E-01 |
| Stage1-vs-Stage2 |
5.598000E-01 |
| Stage1-vs-Stage3 |
6.783800E-02 |
| Stage1-vs-Stage4 |
3.789200E-01 |
| Stage2-vs-Stage3 |
1.384650E-01 |
| Stage2-vs-Stage4 |
2.842600E-01 |
| Stage3-vs-Stage4 |
6.218400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.401300E-03 |
| Normal-vs-AfricanAmerican |
3.501100E-03 |
| Normal-vs-Asian |
5.182800E-04 |
| Caucasian-vs-AfricanAmerican |
6.208200E-02 |
| Caucasian-vs-Asian |
1.544410E-02 |
| AfricanAmerican-vs-Asian |
2.788400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.522200E-02 |
| Normal-vs-Female |
5.69249999999855E-05 |
| Male-vs-Female |
1.075980E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.823810E-01 |
| Normal-vs-Age(41-60Yrs) |
1.344270E-03 |
| Normal-vs-Age(61-80Yrs) |
3.714300E-02 |
| Normal-vs-Age(81-100Yrs) |
2.460200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.620800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.981200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.805600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.118400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.348200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.614600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.184000E-02 |
| Normal-vs-Grade 2 |
4.099100E-03 |
| Normal-vs-Grade 3 |
3.610000E-02 |
| Normal-vs-Grade 4 |
4.523000E-01 |
| Grade 1-vs-Grade 2 |
2.526200E-01 |
| Grade 1-vs-Grade 3 |
1.199550E-01 |
| Grade 1-vs-Grade 4 |
6.124400E-02 |
| Grade 2-vs-Grade 3 |
4.084600E-01 |
| Grade 2-vs-Grade 4 |
1.801620E-01 |
| Grade 3-vs-Grade 4 |
4.223800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.462500E-03 |
| Normal-vs-ccB subtype |
3.582300E-03 |
| ccA subtype-vs-ccB subtype |
4.179000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.152200E-04 |
| Normal-vs-N1 |
6.066200E-01 |
| N0-vs-N1 |
3.736200E-01 |
|
|
